Lincoln Pharma's profit up 17% in June quarter
Lincoln Pharmaceuticals just posted its June quarter results, and investors took notice—shares shot up 9%.
The company's net profit climbed 17% to ₹28 crore, with revenue also ticking up by 5%.
Even though profit margins stayed at 15%, operational numbers like EBITDA grew, showing the business is running strong.
Looking ahead, Lincoln Pharma wants to hit ₹1,000 crore in revenue
Looking ahead, Lincoln Pharma wants to hit ₹1,000 crore in revenue within three years by expanding into new product lines and markets—think heart health, diabetes care, skin treatments, and ENT.
After the earnings news, shares landed at ₹573.90 (up over 8% for the day), but it's been a bumpy ride lately: only a tiny gain this month and still down a hefty 33% for the year.
Investors are watching closely to see if these big plans pay off.